Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids

PHASE3TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

January 31, 2006

Conditions
Schizophrenia
Interventions
DRUG

Olanzapine, Omega 3, Vitamin E+C

No adverse event nor SAE noted.

Trial Locations (1)

30904

VA Medical Center, Augusta

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Medical Service Line ABRC

UNKNOWN

collaborator

US Department of Veterans Affairs

FED

lead

Augusta University

OTHER